Bariatric surgery (BS) is an effective intervention for obesity, inducing significant neurobiological and gut microbiota changes that influence hunger, appetite, taste perception, and long-term metabolic health. This narrative review examines these alterations by analyzing recent findings from clinical and preclinical studies, including neuroimaging, microbiome sequencing, and hormonal assessments. BS modulates appetite-regulating hormones, reducing ghrelin while increasing glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY), leading to enhanced satiety and decreased caloric intake. Neuroimaging studies reveal structural and functional changes in brain regions involved in reward processing and cognitive control, contributing to reduced cravings and altered food choices. Additionally, BS reshapes the gut microbiota, increasing beneficial species such as Akkermansia muciniphila, which influence metabolic pathways through short-chain fatty acid production and bile acid metabolism. These findings highlight the complex interplay between the gut and the brain in post-surgical metabolic regulation. Understanding these mechanisms is essential for optimizing post-operative care, including nutritional strategies and behavioral interventions. Future research should explore how these changes impact long-term outcomes, guiding the development of targeted therapies to enhance the recovery and quality of life for BS patients.
Background: Hypertension contributes substantially to morbidity and mortality, yet patients who rely on the emergency department (ED) may experience gaps in blood pressure management. Although pharmacist-led hypertension programs can improve blood pressure, little is known about ED patients’ perspectives. We explored patient perspectives regarding the acceptability of pharmacist-led hypertension management after ED discharge. Methods: We conducted a qualitative study of adults presenting to an urban academic ED from September–December 2025 with likely undiagnosed or undertreated hypertension. Semi-structured interviews examined experiences managing hypertension, communication preferences, and perspectives on pharmacist-led follow-up. Transcripts underwent thematic analysis incorporating deductive and inductive coding. Results: Eleven participants completed interviews. Four themes were identified: limited hypertension-related communication and knowledge gaps, technology mitigating barriers to blood pressure management, pharmacists’ expertise and scope, and the importance of rapport and accessibility. Participants described competing responsibilities, time constraints, and limited discussion of hypertension during ED visits. Many favored technology-enabled communication and home monitoring. Most viewed pharmacist-led follow-up favorably because of pharmacists’ medication expertise and accessibility, but some expressed uncertainty about pharmacists’ clinical training, prescribing authority, and accountability. Participants also valued continuity and collaboration between pharmacists and physicians. Conclusion: In this small sample, most participants viewed pharmacist-led hypertension management after ED discharge favorably while identifying factors that may affect acceptance. Programs should clearly communicate pharmacists’ qualifications and scope, make physician collaboration visible, and balance convenient technology-enabled care with relational continuity.